284 related articles for article (PubMed ID: 9185754)
1. The successful treatment of symptomatic, refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt.
Gordon FD; Anastopoulos HT; Crenshaw W; Gilchrist B; McEniff N; Falchuk KR; LoCicero J; Lewis WD; Jenkins RL; Trey C
Hepatology; 1997 Jun; 25(6):1366-9. PubMed ID: 9185754
[TBL] [Abstract][Full Text] [Related]
2. [Percutaneous intrahepatic portosystemic shunting as a treatment for refractory hepatic hydrothorax].
Núñez O; García A; Rincón D; Alonso S; Echenagusía A; Bañares R
Gastroenterol Hepatol; 2002 Mar; 25(3):143-7. PubMed ID: 11864535
[TBL] [Abstract][Full Text] [Related]
3. Transjugular intrahepatic portal systemic shunt for the management of symptomatic cirrhotic hydrothorax.
Strauss RM; Martin LG; Kaufman SL; Boyer TD
Am J Gastroenterol; 1994 Sep; 89(9):1520-2. PubMed ID: 8079930
[TBL] [Abstract][Full Text] [Related]
4. Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage.
Sahagun G; Benner KG; Saxon R; Barton RE; Rabkin J; Keller FS; Rosch J
Am J Gastroenterol; 1997 Sep; 92(9):1444-52. PubMed ID: 9317060
[TBL] [Abstract][Full Text] [Related]
5. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
[TBL] [Abstract][Full Text] [Related]
6. [A case of refractory hepatic hydrothorax that was not treated by transjugular intrahepatic portosystemic shunt].
Park HW; Huh W; Kim SJ; Shin WC; Choi WC; Lee JH
Taehan Kan Hakhoe Chi; 2002 Sep; 8(3):327-30. PubMed ID: 12499792
[TBL] [Abstract][Full Text] [Related]
7. Transjugular intrahepatic portosystemic shunt in refractory hydrothorax - a contribution to an unexplored indication.
Campos S; Gomes D; Sofia C
Eur J Gastroenterol Hepatol; 2016 Jun; 28(6):661-6. PubMed ID: 27002676
[TBL] [Abstract][Full Text] [Related]
8. Transjugular intrahepatic portosystemic shunts: experience in the oncology setting.
Wallace MJ; Madoff DC; Ahrar K; Warneke CL
Cancer; 2004 Jul; 101(2):337-45. PubMed ID: 15241832
[TBL] [Abstract][Full Text] [Related]
9. Transjugular intrahepatic portosystemic shunts for refractory ascites after liver transplantation.
Abouljoud M; Yoshida A; Kim D; Jerius J; Arenas J; Raoufi M; Brown K; Moonka D
Transplant Proc; 2005 Mar; 37(2):1248-50. PubMed ID: 15848685
[TBL] [Abstract][Full Text] [Related]
10. Transjugular intrahepatic portosystemic shunts and liver transplantation in patients with refractory hepatic hydrothorax.
Jeffries MA; Kazanjian S; Wilson M; Punch J; Fontana RJ
Liver Transpl Surg; 1998 Sep; 4(5):416-23. PubMed ID: 9724480
[TBL] [Abstract][Full Text] [Related]
11. Treatment of refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt: long-term results in 40 patients.
Siegerstetter V; Deibert P; Ochs A; Olschewski M; Blum HE; Rössle M
Eur J Gastroenterol Hepatol; 2001 May; 13(5):529-34. PubMed ID: 11396532
[TBL] [Abstract][Full Text] [Related]
12. Cirrhotic patients with a transjugular intrahepatic portosystemic shunt undergoing major extrahepatic surgery.
Kim JJ; Dasika NL; Yu E; Fontana RJ
J Clin Gastroenterol; 2009 Jul; 43(6):574-9. PubMed ID: 19169145
[TBL] [Abstract][Full Text] [Related]
13. Transjugular intrahepatic portosystemic shunt--role in treating intractable variceal bleeding, ascites, and hepatic hydrothorax.
LaBerge JM
Clin Liver Dis; 2006 Aug; 10(3):583-98, ix. PubMed ID: 17162229
[TBL] [Abstract][Full Text] [Related]
14. Comparison of transjugular intrahepatic portosystemic shunt dysfunction in PTFE-covered stent-grafts versus bare stents.
Barrio J; Ripoll C; Bañares R; Echenagusia A; Catalina MV; Camúñez F; Simó G; Santos L
Eur J Radiol; 2005 Jul; 55(1):120-4. PubMed ID: 15950109
[TBL] [Abstract][Full Text] [Related]
15. Transjugular intrahepatic portosystemic shunt (TIPS) placement: A comparison of outcomes between patients with hepatic hydrothorax and patients with refractory ascites.
Young S; Bermudez J; Zhang L; Rostambeigi N; Golzarian J
Diagn Interv Imaging; 2019 May; 100(5):303-308. PubMed ID: 30522911
[TBL] [Abstract][Full Text] [Related]
16. Predictors of clinical response to transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients with refractory ascites.
Deschênes M; Dufresne MP; Bui B; Fenyves D; Spahr L; Roy L; Lafortune M; Pomier-Layrargues G
Am J Gastroenterol; 1999 May; 94(5):1361-5. PubMed ID: 10235219
[TBL] [Abstract][Full Text] [Related]
17. [Hepatic hydrothorax].
Bozkurt S; Stein J; Teuber G
Z Gastroenterol; 2005 Dec; 43(12):1319-28. PubMed ID: 16315128
[TBL] [Abstract][Full Text] [Related]
18. [Transjugular intrahepatic portosystemic shunt in the treatment of refractory ascites in 21 patients].
Vandistel G; Nevens F; Stockx L; Raat H; Wilms G; Fevery J
Ned Tijdschr Geneeskd; 1996 Dec; 140(49):2455-8. PubMed ID: 8999346
[TBL] [Abstract][Full Text] [Related]
19. Transjugular intrahepatic portosystemic shunt (TIPS) in patients with refractory ascites: effect on body weight and Child-Pugh score.
Trotter JF; Suhocki PV; Rockey DC
Am J Gastroenterol; 1998 Oct; 93(10):1891-4. PubMed ID: 9772050
[TBL] [Abstract][Full Text] [Related]
20. The outcome after transjugular intrahepatic portosystemic shunt (TIPS) for hepatic hydrothorax is closely related to liver dysfunction: a long-term study in 28 patients.
Wilputte JY; Goffette P; Zech F; Godoy-Gepert A; Geubel A
Acta Gastroenterol Belg; 2007; 70(1):6-10. PubMed ID: 17619531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
